# Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone

> **NCT02900092** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 10 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Ganaxolone

## Key facts

- **NCT ID:** NCT02900092
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2018-01-12
- **Final completion:** 2018-01-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02900092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02900092, "Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02900092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*